» Articles » PMID: 12442315

Localization of the Slack Potassium Channel in the Rat Central Nervous System

Overview
Journal J Comp Neurol
Specialty Neurology
Date 2002 Nov 21
PMID 12442315
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

The Slack gene encodes a voltage-dependent K(+) channel that has a unitary conductance of approximately 60 pS. Evidence from heterologous expression studies suggests that Slack channel subunits can also combine with the Slo subunit to generate Ca(2+)-activated K(+) channels of larger conductances. Nonetheless, the function of Slack in the brain remains to be identified. We have now generated an affinity-purified antibody against the N-terminal of rat Slack, for biochemical and immunohistochemical studies. The antibody recognized Slack in transiently transfected CHO cells both by immunocytochemistry and by Western blot analysis. The antibody also detected a single band in rat brain membranes. The localization of Slack in rat brain slices was then determined using the antibody. Most prominent Slack immunoreactivity occurs in the brainstem, in particular the trigeminal system and reticular formation, where very intense staining was found in both cell bodies and axonal fibers of associated nuclei. Labeling was also very strong in the vestibular and oculomotor nuclei. Within the auditory system, the medial nucleus of the trapezoid had a robust signal consistent with staining of the giant presynaptic terminals. Strong Slack immunoreactivity was present in the olfactory bulb, red nucleus, and deep cerebellar nuclei. There was labeling also in the thalamus, substantia nigra, and amygdala. The only cortical region in which Slack immunoreactivity was detected was the frontal cortex. The subcellular and regional distribution of Slack differs from that previously reported for the Slo channel subunit and suggests that Slack may also have an autonomous role in regulating the firing properties of neurons.

Citing Articles

Electrophysiological characterization of human KCNT1 channel modulators and the therapeutic potential of hydroquinine and tipepidine in KCNT1 mutation-associated epilepsy mouse model.

Guo Q, Gan J, Wang E, Wei Y, Xu J, Xu Y Acta Pharmacol Sin. 2025; .

PMID: 39870847 DOI: 10.1038/s41401-024-01457-8.


Structure-Activity Relationship Studies in a Series of 2-Aryloxy--(pyrimidin-5-yl)acetamide Inhibitors of SLACK Potassium Channels.

Mishra N, Spitznagel B, Du Y, Mohamed Y, Qin Y, Weaver C Molecules. 2024; 29(23).

PMID: 39683653 PMC: 11643494. DOI: 10.3390/molecules29235494.


Molecular Profiling of Mouse Models of Loss or Gain of Function of the KCNT1 (Slack) Potassium Channel and Antisense Oligonucleotide Treatment.

Sun F, Wang H, Wu J, Quraishi I, Zhang Y, Pedram M Biomolecules. 2024; 14(11).

PMID: 39595574 PMC: 11591899. DOI: 10.3390/biom14111397.


Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies.

Shabani K, Krupp J, Lemesre E, Levy N, Tran H Cells. 2024; 13(21.

PMID: 39513870 PMC: 11544952. DOI: 10.3390/cells13211763.


Heterozygous expression of a gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons.

Shore A, Li K, Safari M, Qunies A, Spitznagel B, Weaver C Elife. 2024; 13.

PMID: 39392867 PMC: 11469685. DOI: 10.7554/eLife.92915.